000			01855 a2200457 4500
005			20250514182836.0
264		0	_c20041209
008			200412s 0 0 eng d
022			_a1476-4598
024	7		_a10.1186/1476-4598-3-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aAndela, Valentine B
245	0	0	_aThe proteosome inhibitor MG132 attenuates retinoic acid receptor trans-activation and enhances trans-repression of nuclear factor kappaB. Potential relevance to chemo-preventive interventions with retinoids. _h[electronic resource]
260			_bMolecular cancer _cMar 2004
300			_a8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aActive Transport, Cell Nucleus _xphysiology
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Nucleus _xmetabolism
650	0	4	_aDNA, Neoplasm _xmetabolism
650	0	4	_aDNA-Binding Proteins _xantagonists & inhibitors
650	0	4	_aEnzyme Activation _xphysiology
650	0	4	_aGene Expression Regulation _xphysiology
650	0	4	_aHumans
650	0	4	_aLeupeptins _xpharmacology
650	0	4	_aLigands
650	0	4	_aMacromolecular Substances _xantagonists & inhibitors
650	0	4	_aMatrix Metalloproteinase 9 _xmetabolism
650	0	4	_aNF-kappa B _xgenetics
650	0	4	_aNeoplasm Metastasis _xpathology
650	0	4	_aNeoplasm Proteins
650	0	4	_aProtein Transport _xphysiology
650	0	4	_aReceptors, Retinoic Acid _xantagonists & inhibitors
650	0	4	_aRepressor Proteins _xphysiology
650	0	4	_aRetinoids
650	0	4	_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism
650	0	4	_aTranscriptional Activation _xdrug effects
700	1		_aRosier, Randy N
773	0		_tMolecular cancer _gvol. 3 _gp. 8
856	4	0	_uhttps://doi.org/10.1186/1476-4598-3-8 _zAvailable from publisher's website
999			_c14753107 _d14753107